Alarmingly High Whooping Cough Cases Claim 12 Lives in the Czech Republic This Year
2024-11-04
Author: Daniel
Alarmingly High Whooping Cough Cases Claim 12 Lives in the Czech Republic This Year
In a concerning development, the State Health Institute (SZU) has reported that twelve lives, predominantly among senior citizens, have been lost to whooping cough (pertussis) in the Czech Republic in 2023. This alarming statistic marks one of the highest death tolls from this preventable disease in decades.
The outbreak has seen a steadier rise in infections, with 2,333 new cases recorded since late September, but overall, the pace of new infections has slowed in recent weeks. To date, over 34,000 individuals across the nation have contracted the illness this year—the most significant spike since vaccination efforts began in the late 1950s.
Health officials highlight the vulnerability of the elderly and those with chronic health conditions. These groups often possess weakened immune systems, increasing their risk of severe infections and complications. Stepanka Cechova, spokesperson for SZU, emphasized the critical need for vaccinations, particularly for seniors living in residential care facilities. “They should definitely consider vaccination against selected diseases, including influenza, COVID-19, pneumococci, and pertussis,” she advised.
Children under one year old are also at great risk, having reported 615 cases of whooping cough this year. Tragically, two of those affected were infants who succumbed due to complications from multiple infections.
Symptoms of whooping cough begin similarly to a common cold, with a runny nose, mild fever, and sore throat. However, after about two weeks, a severe, choking cough develops, often worsening at night. In severe cases among young children, there’s a risk of respiratory arrest, making early diagnosis and treatment with antibiotics essential.
Fortunately, vaccinations are available. The whooping cough vaccine is incorporated in the hexavalent vaccine—administered at ages nine weeks, four months, and 11-12 months—and a booster is recommended at ages 10-11 years. Currently, the most affected demographic appears to be those aged 15-19, likely due to a decrease in vaccine effectiveness as time passes following their last vaccination. Experts are urging adults to seek at least one booster vaccination, although individuals will need to cover the cost themselves and inquire about possible reimbursements from their health insurance providers.
With the rising case numbers and tragic fatalities, it becomes crucial for communities to prioritize vaccination and stay informed about whooping cough's risks. The 2023 outbreak serves as a vital reminder of the importance of vaccine uptake to protect both vulnerable populations and the broader community.